Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01008930 · ClinicalTrials.gov registry record · NA
Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01008930: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT01008930 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01008930, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if using the PEMFlex Solo II, a high-resolution camera for PET scan imaging, on an area of the body that has, or is suspected to have cancer will give researchers the same or better information about the disease compared to the images taken with a routine PET/CT. Researchers will compare the images taken using the PEMFlex Solo II to the images taken during your scheduled routine PET/CT scan, as well as any additional routine CT scan(s), magnetic resonance imaging (MRI) scan(s), and/or ultrasound image(s) you may have had within the last 30 days or may have in the next 30 days.
Interventions
- PROCEDURE HR PEM Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01008930
The ClinicalTrials.gov registry entry for NCT01008930 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HR PEM Scan is the first listed.
NCT01008930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01008930 about?
NCT01008930 is a clinical study titled "Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System". The goal of this clinical research study is to learn if using the PEMFlex Solo II, a high-resolution camera for PET scan imaging, on an area of the body that has, or is suspected to have cancer will give researchers the same or better information about the disease compared to the images taken with a...
What is the current status of trial NCT01008930?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2009-12.
What interventions are being tested in trial NCT01008930?
The interventions under investigation include: HR PEM Scan (PROCEDURE).
Who is sponsoring clinical trial NCT01008930?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.